by John Conrad | Jul 19, 2024 | iBIO News
NewsBrief Weekly News Quiz: July 19th Friday Biotech Buzz: Weekly Knowledge Challenge 🧬🔬 Calling all life science aficionados! It’s time for our weekly iBIO NewsBrief Quiz. How well have you kept up with the latest breakthroughs? Let’s put your...
by John Conrad | Jul 18, 2024 | NewsBrief
GE HealthCare announced today that it has entered into an agreement to acquire the clinical artificial intelligence (AI) software business of Intelligent Ultrasound Group PLC for approximately $51 million. The acquisition aims to integrate innovative AI-driven image...
by John Conrad | Jul 17, 2024 | NewsBrief
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, announced that its multimodal immune profile score (IPS) algorithmic test is now available for research use only (RUO). IPS is the first offering of a larger immunotherapy-based...
by John Conrad | Jul 17, 2024 | NewsBrief
A groundbreaking medical device designed to improve breast cancer treatment has successfully completed its first human trial. Innoblative Designs, Inc., a Chicago-based medical device company, announced on July 16, 2024, that its SIRA® RFA Electrosurgical Device was...
by John Conrad | Jul 11, 2024 | NewsBrief
Chicago-based ImmersiveTouch Inc. has announced a major breakthrough in medical technology with FDA 510(k) clearance for its augmented reality (AR) surgical platform, ImmersiveAR™. This innovative system is set to transform operating room procedures by bringing...
